Celiac Science
$15 Million Invested in Cell Therapy That Could Transform How Celiac Disease Is Treated
A Philadelphia biotech raised $15.1M to develop cell-based therapies for autoimmune disease. Here's what that investment signals for celiac families watching the treatment pipeline.